MedTrace Logo

Prenatal Testing: Amniocentesis Versus Transabdominal Chorionic Villus Sampling (TA CVS)

NCT00065897 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6400

Last updated 2005-06-24

No results posted yet for this study

Summary

Prenatal diagnosis can provide information to parents about specific fetal disorders. However, invasive prenatal diagnostic procedures are associated with risks to the fetus. This study will compare the safety and effectiveness of two methods of invasive prenatal diagnosis: amniocentesis and transabdominal chorionic villus sampling (TA CVS).

Conditions

  • Pregnancy

Interventions

PROCEDURE

Amniocentesis

PROCEDURE

Transabdominal chorionic villus sampling (TA CVS)

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    lead NIH

Principal Investigators

  • Laird G. Jackson, M.D. · Drexel University College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
34 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1996-09-30
Completion
2000-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00065897 on ClinicalTrials.gov